Every preparation.

Synthetic pentadecapeptide derived from human gastric juice — broad tissue-repair signalling.

Synthetic version of Thymosin β-4 — actin regulation, angiogenesis and cell migration in injured tissue.

α-MSH C-terminal tripeptide with strong anti-inflammatory action.

Mitochondrial-targeted tetrapeptide — preserves cardiolipin under oxidative stress.

Copper tripeptide — extracellular matrix remodelling and skin regeneration.

Tetrapeptide derived from epithalamin — telomerase activity and circadian alignment.

Thymus-derived peptide complex — immune homeostasis in ageing.

Synthetic dipeptide derived from Thymalin — narrow immunomodulatory profile.

28-aa peptide that modulates T-cell function — used clinically in immune-compromised states.

Mitochondrial-derived peptide — AMPK activation, glucose homeostasis, exercise mimetic.

Polyamine — autophagy inducer studied for cardiovascular and cognitive ageing.

Delta sleep-inducing peptide — slow-wave sleep modulation and stress resilience.

Myostatin antagonist — investigational support for lean-mass preservation.

Long-acting IGF-1 analogue — anabolic and neurotrophic signalling.

28-aa peptide regulating immune, neural and vascular function.

GHRH analogue that prompts the pituitary to release endogenous growth hormone in physiological pulses.

Selective ghrelin-receptor agonist with minimal cortisol or prolactin elevation.

First-generation GH-releasing hexapeptide with appetite-stimulating side effect.

GHRH analogue — DAC variant gives sustained release, NO-DAC mimics native pulsatility.

Long-acting GHRH analogue used clinically for visceral adipose reduction.

ACTH(4–10) analogue — BDNF/NGF upregulation, attention and stress tolerance.

Synthetic analogue of tuftsin — anxiolytic action without sedation.

Melanocortin agonist acting centrally on sexual arousal pathways.

Kiss1-derived decapeptide — upstream regulator of GnRH and the reproductive axis.

Nonapeptide hormone — bonding, intimacy and prosocial neuromodulation.

Linear α-MSH analogue — melanocyte stimulation and photoprotective research.

Cyclic α-MSH analogue — pigmentation and sexual arousal pathways.

GLP-1 receptor agonist for appetite regulation and glycemic control.

Dual GIP/GLP-1 agonist — broader metabolic effect than GLP-1 mono-agonists.

Triple GLP-1/GIP/glucagon agonist — under clinical investigation for advanced metabolic protocols.

Long-acting amylin analogue — satiety regulation, often stacked with GLP-1.

GH fragment (177-191) — targets lipolysis without systemic GH effects.

NNMT inhibitor — investigational support for metabolic flexibility and fat oxidation.

Glycoprotein hormone — LH-mimetic, used to stimulate endogenous testosterone and fertility.

Combined FSH/LH activity — adjunctive use in HPG-axis recovery and fertility.

Recombinant human growth hormone — physician-supervised use only.